Alcidion Group Limited · ASX:ALC
Alcidion — Shareholder Meeting (October 2024)
42 slides from Alcidion's shareholder meeting presentation, Oct 23, 2024
Slide 1: 2024 Annual General Meeting Chair Address and Presentation
23 October 2024 Australian Securities Exchange 20 Bridge Street Sydney NSW 2000 2024 Annual General Meeting Chair Address and Presentation Melbourne, Australia – Alcidion Group Limited (ASX: ALC) (Alcidion or Company) advises in accordance with ASX Listing Rule 3.13.3, a copy of the address by Chair
Slide 2: Chair's Address
Chair’s Address As Chair of the Board, I’m pleased to stand before you today to reflect on our year and share our vision and optimism for the future. The fundamentals of Alcidion’s business remain strong and highly relevant in an environment of continued and growing pressures on healthcare systems w
Slide 3: Chair's Address (continued)
In July we signed a $4M contract with Hume Rural Health Alliance for the use of Miya Precision as an enterprise digital platform with a focus on patient flow and virtual care. This is a significant deal in that it is regional, covering 15 hospitals. I’m pleased to report that we are on track to go l
Slide 4: Annual General Meeting
Annual General Meeting 23 OCTOBER 2024
Slide 5: Introduction
INTRODUCTION
Slide 6: Acknowledgement of Country
ACKNOWLEDGEMENT OF COUNTRY Alcidion acknowledges the Traditional Custodians of the land we live and work upon and pay our respects to Elders past and present. COMMERICAL IN CONFIDENCE
Slide 7: Alcidion Group Board
Alcidion Group Board Rebecca Wilson Kate Quirke Daniel Sharp Non-Executive Chair Group Managing Director | CEO Non-Executive Director Simon Chamberlain Victoria Weekes William Smart Non-Executive Director Non–Executive Director Non–Executive Director (retiring at the conclusion of today’s AGM)
Slide 8: Format of Meeting
Format of Meeting 01 02 Chair Address Annual General Meeting Presentation 03 04 Q&A / Voting Procedure Formal Business of the Overview Meeting 05 General Questions
Slide 9: Chair Address
01 Chair Address
Slide 10: Annual General Meeting Presentation
02 Annual General Meeting Presentation
Slide 11: FY24 AGM Presentation
FY24 AGM Presentation Presenting: Kate Quirke - Group MD & CEO Nick White - CMO 23 October 2024
Slide 12: Smarter Solutions for Clinicians
Smarter Solutions for Clinicians BY ALCIDION Powering Smarter Care At the core of the Alcidion solution is our Patient Virtual Operations Specialised FHIR-based interoperability platform for Flow Care Centre Care smarter decision support Industry leading Virtual care and Integrated Emergency digital
Slide 13: A sample of our customers
A sample of our customers . . . Alfred Health Western Health NT Health Journey Boards & Operations Management Patient Flow, Capacity Management Patient Flow & Command Capability South Tees NHS Trust Australian Defence Force Dartford & Gravesham NHS Miya Electronic Patient Record (EPR) Longitudinal H
Slide 14: Global Operations
Global Operations… Current Operations Future Geographical Expansion Key Criteria: Australia & New United • Sizable market Zealand Kingdom • English speaking (reduced development spend) • Healthcare structure similar to UK / Australia • Access to digital healthcare data 51% FY24 Revenue Target locati
Slide 15: Customer Success
Customer Success
Slide 16: Notable Contract Wins & Renewals
Notable Contract Wins & Renewals New contracts reinforce modular strategy, catering to needs of customers as they enhance their digital maturity Hume Rural Health Alliance (AUS) South Tees NHS Trust (UK) • TCV of $4.0m over 5 years • Signed $23.3M contract extension for an additional 8 years (to 203
Slide 17: EPR Validation: North Cumbria
EPR Validation: North Cumbria Selected as Preferred Supplier by North Cumbria Integrated Care NHS Foundation Trust (NCIC) for new EPR platform solution Preferred Supplier - Overview Anticipated Contract Terms • Selected following a competitive tender process 10 years Contract duration • Deploy Miya
Slide 18: Successful Deployments in FY24
Successful Deployments in FY24 Product Implementation and technical services have always been a strength of the Alcidion business Herefordshire and Worcestershire NHS (UK) Hampshire Hospitals NHS (UK) • First deployment of Miya Precision for Flow • 1st site using Miya Emergency (ED) module and Bed M
Slide 19: FY24 Financials
FY24 Financials
Slide 20: Revenue Dashboard
Revenue Dashboard Revenue Category Breakdown ($M) Recurring ARR (product) % vs. Total Revenue (%) • Recurring product revenue (ARR) of $26.2M, up 6% on pcp • 71% of FY24 revenue classified as ARR – Includes: Annual Maintenance & Support (M&S); Annual recurring licence fee; or Annual subscription fee
Slide 21: Profit & Loss (H1 vs H2 FY24)
Profit & Loss (H1 vs H2 FY24) Significant impact of cost saving initiatives implemented in H2; Alcidion on clear path to profitability Profit & loss (A$000) H1'24 H2'24 % change 1• 19% reduction in staff costs in H2 vs H1 Total revenue 19,059 17,998 (6%) Direct costs (2,322) (2,815) 21% – Tightened
Slide 22: The Impact of Miya
The Impact of Miya DELIVERING MEASURABLE BENEFITS FOR CUSTOMERS
Slide 23: Calculating the impact of Miya
Calculating the impact of Miya Our objective: publication icon PART 1 Recap the DHCRC/Monash To create a business case template… study of Miya Precision at which supports our customers… Alfred Health. to understand and communicate the proven voice icon PART 2 impact of Miya Precision… Present Alcidi
Slide 24: Alfred Health – Independent Study on Miya Precision Benefits
Alfred Health – Independent Study on Miya Precision Benefits In 2023, Alfred Health introduced electronic patient journey boards (EPJBs) to 38 inpatient wards across 3 hospitals. The Digital Health CRC and Monash University used the deployment to conduct an 18-month study on the benefits of EPJBs. 1
Slide 25: Customer reported benefits
Customer reported benefits medical team icon doctors icon hospital billing icon hospital bed Icon 670825 hospital bed Icon 670825 hospital bed Icon 670825 hospital bed Icon 670825 hospital bed Icon 670825 hospital manager icon hospital bed Icon 670825 hospital bed Icon 670825 hospital bed Icon 67082
Slide 26: For an 800-bed healthcare system
For an 800-bed healthcare system… doctors icon hospital bed Icon 670825 hospital bed Icon 670825 hospital bed Icon 670825 hospital bed Icon 670825 hospital bed Icon 670825 hospital billing icon medical team icon hospital manager icon hospital bed Icon 670825 hospital bed Icon 670825 hospital bed Ico
Slide 27: Alcidion delivers over $1bn of value to the global healthcare economy
Alcidion delivers over $1bn of value to the global healthcare economy As a theoretical exercise, we looked at each How big could this impact be if all our of our customers and applied the benefits customers adopted all our modules…. model to estimate Alcidion’s global impact on the healthcare econom
Slide 28: Outlook
Outlook
Slide 29: Outlook
Outlook Increased procurement activity has continued, with re-aligned cost base positioning business well for profitability • As of August 2024, $28.0M of contracted and renewal revenue expected to be recognised in FY25 – Excludes any potential revenue from NCIC (North Cumbria) which would be materi
Slide 30: Investment Highlights
Investment Highlights • Large Addressable Market Strong Financial Profile Marquee Customers • ~146 Acute UK NHS Trusts; ALC with foothold in • ~71% recurring product revenue, supported • Selected as preferred supplier for new EPR only ~27% by multi-year contracts to North Cumbria; TCV $30-40m over 1
Slide 31: Disclaimer
Disclaimer The information contained in this document (“Document”) has been prepared by Alcidion Group Limited ACN 143 142 410 (referred to as “Alcidion” or “Company”). This Document is current as at the date of this Document and should be read in conjunction with other Alcidion periodic and continu
Slide 32: Q&A / Voting Procedure Overview
03 Q&A / Voting Procedure Overview
Slide 33: Formal Business of the Meeting
04 Formal Business of the Meeting
Slide 34: Receipt and Consideration of Financial & Other Reports
Receipt and Consideration of Financial & Other Reports To receive and consider the Financial Report of the Company and the related reports of the Directors (including the Remuneration Report) and Auditors, for the financial year ended 30 June 2024. Further Information › Matt Gepp, Chief Financial Of
Slide 35: Resolution 1 – Adoption of Remuneration Report
Resolution 1 – Adoption of Remuneration Report To consider and, if thought fit, pass the following as an ordinary resolution: “That for the purpose of Section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report (included in the Directors' Report) for the financial yea
Slide 36: Resolution 2 – Re-election of Victoria Weekes
Resolution 2 – Re-election of Victoria Weekes as a Director of the Company To consider and, if thought fit, pass the following as an ordinary resolution: “That Victoria Weekes, being a Director who retires by rotation pursuant to Clause 21.1 of the Constitution and Listing Rule 14.4 and who, being e
Slide 37: Resolution 3 – Re-election of Daniel Sharp
Resolution 3 – Re-election of Daniel Sharp as a Director of the Company To consider and, if thought fit, pass the following as an ordinary resolution: “That Danny Sharp, being a Director who retires by rotation pursuant to Clause 21.1 of the Constitution and Listing Rule 14.4 and who, being eligible
Slide 38: Resolution 4 – Election of William Sharp
Resolution 4 – Election of William Sharp as a Director of the Company To consider and, if thought fit, pass the following as an ordinary resolution: “That William Sharp, who was appointed as an addition to the Board since the last Annual General Meeting of the Company and who retires pursuant to Lis
Slide 39: Resolution 5 – Approval of the Company's Equity Incentive Plan
Resolution 5 – Approval of the Company’s Equity Incentive Plan To consider and, if thought fit, pass the following as an ordinary resolution: “That, for the purposes of Listing Rule 7.2, Exception 13(b) and sections 259B(2) and 260C(4) of the Corporations Act, Shareholders approve the issue of secur
Slide 40: Voting Closure and End of Formal Business
VOTING CLOSURE AND END OF FORMAL BUSINESS
Slide 41: General Questions
05 General Questions
Slide 42: Thank You
THANK YOU FOR YOUR ATTENDANCE